Sleuth Insights, Inc.

Sleuth Insights, Inc. is a US-based company specializing in biopharma intelligence, providing cutting-edge insights through a proprietary knowledge graph that integrates extensive data for strategic decision-making. Founded in 2023, Sleuth Insights, Inc. focuses on delivering biopharma intelligence solutions.

The company is headquartered in San Francisco, US. Andrew Pannu, the founder, has a background in building data-driven companies, enhancing their focus on innovative market solutions. Sleuth Insights offers a proprietary biopharma knowledge graph that integrates over 100 million pre-linked entities, delivering insights into the biopharma industry, including drugs, clinical trials, partnerships, and market positioning. This platform assists biopharmaceutical companies, investment firms, and research organizations in strategic decision-making by providing validated, real-time intelligence from diverse sources including international pipelines and analyst research.

Sleuth Insights operates on a subscription-based revenue model, allowing clients to access its platform through annual retainers. The company structures these transactions as B2B engagements, enabling clients to leverage the platform for customized analyses and insights. While specific pricing is proprietary, offerings include detailed analyses of high-value biopharma datasets and tailored reports, ensuring a consistent income stream while delivering substantial insights to users. In September 2025, Sleuth Insights, Inc.

raised USD 7. 68 million in seed funding led by Bison Ventures. The company plans to use the April 2026 funding to build and scale its biopharma intelligence platform and expand the team supporting product development and analysis.